Nombre del producto:4-(cyclopent-1-en-1-yl)morpholine

IUPAC Name:4-(cyclopent-1-en-1-yl)morpholine

CAS:936-52-7
Fórmula molecular:C9H15NO
Pureza:97%
Número de catálogo:CM163851
Peso molecular:153.23

Unidad de embalaje Stock disponible Precio($) Cantidad
CM163851-25g in stock ƈŗŗ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :936-52-7
Fórmula molecular:C9H15NO
Punto de fusión:-
Código de sonrisas:N1(C2=CCCC2)CCOCC1
Densidad:
Número de catálogo:CM163851
Peso molecular:153.23
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Morpholines
Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.
morpholine price
if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.

Column Infos

Etrasimod
Etrasimod is a new generation of oral S1P receptor modulator, which can specifically bind to S1P receptors 1, 4, and 5. It is being studied for a range of immune inflammatory diseases, including ulcerative colitis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. At present, the highest stage of research and development of the drug is to apply for marketing, which is used to treat ulcerative colitis and is expected to be approved by FDA in this month.